Вы находитесь на странице: 1из 4

DAFTAR PUSTAKA

1. Skariah S, McIntyre MK, Mordue DG. Toxoplasma gondii: determinants of


tachyzoite to bradyzoite conversion. Parasitol Res 2010;107(2):25360.
2. Elmore SA, Jones JL, Conrad PA, Patton S, Lindsay DS, Dubey JP. Toxoplasma
gondii: epidemiology, feline clinical aspects, and prevention. Trends Parasitol
2010;26(4):1906.
3. Dubey JP, Lindsay DS, Lappin MR. Toxoplasmosis and other intestinal coccidial
infections in cats and dogs. Vet Clin North Am Small Anim Pract
2009;39(6):100934, v.
4. Jones JL, Krueger A, Schulkin J, Schantz PM. Toxoplasmosis prevention and
testing in pregnancy, survey of obstetrician-gynaecologists. Zoonoses Public
Health 2010;57(1):2733.
5. Dubey JP, Jones JL. Toxoplasma gondii infection in humans and animals in the
United States. Int J Parasitol 2008;38(11):125778.
6. Di Carlo P, Romano A, Schimmenti MG, Mazzola A, Titone L. Materno-fetal
Toxoplasma gondii infection: critical review of available diagnostic methods.
Infez Med 2008;16(1):2832.
7. Flori P, Chene G, Varlet MN, Sung RT. Toxoplasma gondii serology in pregnant
woman: characteristics and pitfalls [article in French]. Ann Biol Clin (Paris)
2009;67(2):12533.
8. Montoya JG. Laboratory diagnosis of Toxoplasma gondii infection and
toxoplasmosis. J Infect Dis 2002;185(Suppl 1):S7382.
9. McLeod R, Kieffer F, Sautter M, Hosten T, Pelloux H. Why prevent, diagnose and
treat congenital toxoplasmosis? Mem Inst Oswaldo Cruz 2009;104(2):32044.
10. Di Mario S, Basevi V, Gagliotti C, Spettoli D, Gori G, DAmico R, et al. Prenatal
education for congenital toxoplasmosis. Cochrane Database Syst Rev 2009;
(1):CD006171.
11. Banerji A, Ford-Jones EL, Kelly E, Robinson JL. Congenital rubella syndrome
despite maternal antibodies. CMAJ 2005 Jun 21;172(13):16789.
12. Edlich RF, Winters KL, Long WB 3rd, Gubler KD. Rubella and congenital rubella
(German measles). J Long Term Eff Med Implants 2005;15(3):31928.
13. Bullens D, Smets K, Vanhaesebrouck P. Congenital rubella syndrome after
maternal reinfection. Clin Pediatr (Phila) 2000;39:1136.

14. Aboudy Y, Fogel A, Barnea B, Mendelson E, Yosef L, Frank T. Subclinical


rubella reinfection during pregnancy followed by transmission of virus to the
fetus. J Infect 1997;34:2736.
15. Robinson J, Lemay M, Vaudry WL. Congenital rubella after anticipated
immunity: two cases and a review of the literature. Pediatr Infect Dis
1994;13:8125.
16. Frey TK, Abernathy ES. Identification of strain-specific neucleotide sequences in
the RA 27/3 rubella vaccine. J Infect Dis 1993;168:85464.
17. Bosma TJ, Corbett KM, Eckstein MB, OShea S, Vijayalakshmi P, Banatvala JE,
et al. Use of PCR for prenatal and postnatal diagnosis of congenital rubella. J Clin
Microbiol 1995 Nov;33(11):28817.
18. Ho-Terry L, Terry GM, Londesborough P. Diagnosis of foetal rubella virus
infection by polymerase chain reaction. J Gen Virol 1990; 71 (Pt 7):160711.
19. Tanemura MJ, Suzumori K, Yagami Y, Katow S. Diagnosis of fetal rubella
infection with reverse transcription and nested polymerase chain reaction: a study
of 34 cases diagnosed in fetuses. Am J Obstet Gynecol 1996;174:57882.
20.Revello MG, Gerna G. Diagnosis and management of human cytomegalovirus
infection in the mother, fetus, and newborn infant. Clin Microbiol Rev
2002;15:680715.
21. Revello MG, Gerna G. Diagnosis and management of human cytomegalovirus
infection in the mother, fetus, and newborn infant. Clin Microbiol Rev
2002;15:680715.
22. Lipitz S, Achiron R, Zalel Y, Mendelson E, Tepperberg M, Gamzu R. Outcome of
pregnancies with vertical transmission of primary cytomegalovirus infection.
Obstet Gynecol 2002;100:42833.
23. Malinger G, Lev D, Zahalka N, Ben Aroia Z, Watemberg N, Kidron D, et al. Fetal
cytomegalovirus infection of the brain: the spectrum of sonographic findings.
AJNR Am J Neuroradiol 2003;24:2832.
24.Ornoy A, Diav-Citrin O. Fetal effects of primary and secondary cytomegalovirus
infection in pregnancy. Reprod Toxicol 2006;21:399409.
25.Picone O, Simon I, Benachi A, Brunelle F, Sonigo P. Comparison between
ultrasound

and

magnetic

resonance

imaging

in

cytomegalovirus infection. Prenat Diagn 2008;28:7538.

assessment

of

fetal

26.Benoist G, Salomon LJ, Mohlo M, Suarez B, Jacquemard F, Ville Y.


Cytomegalovirus-related fetal brain lesions: comparison between targeted
ultrasound examination and magnetic resonance imaging. Ultrasound Obstet
Gynecol 2008; Epub ahead of print.
27.Nigro G, Adler SP, La Torre R, Best AM. Passive immunization during pregnancy
for congenital cytomegalovirus infection. N Engl J Med 2005;353:135062.
28.Adler SP, Nigro G, Pereira L. Recent advances in the prevention and treatment of
congenital cytomegalovirus infections. Semin Perinatol 2007;31:108.
29.Demmler GJ. Screening for congenital cytomegalovirus infection: a tapestry of
controversies, J Pediatr 2005;146:1624.
30.Naessens A, Casteels A, Decatte L, Foulon W. A serologic strategy for detecting
neonates

at

risk

for

congenital

cytomegalovirus

infection.

Pediatr

2005;146:1947.
31. Sheffield JS, Hill JB, Hollier LM, Laibl VR, Roberts SW, Sanchez PJ, et al.
Valacyclovir prophylaxis to prevent recurrent herpes at delivery: a
randomized clinical trial. Obstet Gynecol 2006;108:1417.
32. Andrews WW, Kimberlin DF, Whitley R, Cliver S, Ramsey PS, Deeter R.
Valacyclovir therapy to reduce recurrent genital herpes in pregnant women.
Am J Obstet Gynecol 2006;194:77481.
33. Corey L, Wald A, Patel R, Sacks SL, Tyring SK, Warren T, et al. Once-daily
valacyclovir to reduce the risk of transmission of genital herpes. N Engl J
Med 2004;350:1120.
34. Money D, Steben M. Genital herpes: gynaecological aspects. SOGC Clinical
Practice Guideline No. 207, April 2008. J Obstet Gynaecol Can
2008;30:347353.
35. Wong T. Neonatal herpes simplex infection. Canadian Pediatric Society
Surveillance Program Data, 2002.
36. Prevention and Control of Occupational Infections in Health Care,
Canadian Communicable Disease Report, Volume 28S1, March 2002.
37. Woolf SH, Battista RN, Anderson GM, Logan AG, Eel W. Canadian Task force on
Preventive Health Care. New grades for recommendations from the Canadian
Task force on Preventive Health Care. CMAJ 2003;169:2078.

38.

Вам также может понравиться